Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders

Pharmacology Biochemistry and Behavior(2022)10.1016/j.pbb.2022.173493Source: DataRank Database

Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders is a research paper published in Pharmacology Biochemistry and Behavior (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.01)OA: greenTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Jason Putnam,P. Jeffrey Conn ORCID,Shalini Dogra ORCID

Live enrichment

PubMed:36402243 PMC:PMC9729465 OpenAlex:https://openalex.org/W4309436811

National Institutes of Health

Grant: R01MH062646

National Institutes of Health

Grant: R01NS031373

NIMH NIH HHS

Grant: R01 MH119673

NIMH NIH HHS

Grant: R01 MH074953

Boehringer Ingelheim

ACADIA Pharmaceuticals

FWCI

1.01

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9729465

publisherhttps://api.elsevier.com/content/article/PII:S0091305722001721?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0091305722001721?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.pbb.2022.173493

Fields of Study

Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and SignalingMemory and Neural Mechanisms

MeSH Terms

Central Nervous SystemHumansNervous System DiseasesReceptors, Metabotropic GlutamateGlutamic Acid

Keywords

NeuroscienceMetabotropic glutamate receptorGlutamatergicGlutamate receptorMetabotropic receptorMetabotropic glutamate receptor 5AddictionReceptorMedicinePharmacologyPsychologyInternal medicineGlutamateSchizophreniaCognitionDepressionAntidepressantsSubstance Use DisordersNeurodevelopmental DisordersMglu5Mglu3

Sustainable Development Goals

SDG 0: Good health and well-being

Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders

FAIR Checklist

Authors (3)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)